期刊文献+

阿托伐他汀钙对高血压冠心病患者IMT厚度及血脂和心功能的影响 被引量:26

Effects of atorvastatin calcium on IMT thickness,blood fat and cardiac function of patients with hypertension complicated by coronary heart disease
下载PDF
导出
摘要 目的探究阿托伐他汀钙对高血压冠心病患者颈动脉内膜、中膜厚传(IMT)厚度及血脂和心功能的影响分析,为高血压合并冠心病的治疗提供理论依据。方法 100例高血压合并冠心病患者,通过回顾性分析的探究方式进行疗效比较。将使用缬沙坦联合氨氯地平治疗的50例患者设为对照组,将阿托伐他汀钙联合氨氯地平治疗的50例患者设为观察组。连续治疗2个月后比较2组患者治疗前后收缩压(SBP)、舒张压(DBP)以及高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、三酰甘油(TG)、总胆固醇(TC)等血脂指标水平变化,并检测两组患者治疗前后颈动脉内膜-中膜(IMT)厚度,通过超声心动图检查治疗前后心脏左室舒张末内径(LVDD)以及左心室射血分数(LVEF)。结果 2组治疗后SBP、DBP均较治疗前显著降低,且观察组显著低于对照组,差异有统计学意义(P<0.01);2组治疗前后HDL-C差异无统计学意义(P>0.05),2组治疗后LDL-C、TG、TC均显著降低,且观察组显著低于对照组,差异有统计学意义(P<0.01);2组治疗后IMT厚度、LVDD显著降低,LVEF显著升高,且2组治疗后比较,差异有统计学意义(P<0.01)。结论在常规降压治疗基础上采用阿托伐他汀钙能显著降低高血压合并冠心病患者血压,改善血脂水平,提高心脏功能,降低IMT厚度以延缓动脉粥样硬化。 Objective To analyze the effects of atorvastatin calcium on IMT thickness,blood lipid and cardiac function of patients with hypertension and coronary heart disease so as to provide theory gist for treatment of hypertension complicated by coronary artery disease. Methods A total of 100 patients with hypertension complicated by coronary heart disease were divided into observation group( n = 50) and control group( n = 50). The patients in observation group were treated by atorvastatin calcium combined with amlodipine,however,the patients in control group were treated by valsartan combined with amlodipine. After 2-month treatment,the changes of systolic blood pressure( SBP),diastolic blood pressure( DBP),high density lipoprotein( HDLC),low density lipoprotein( LDLC),triglyceride( TG) and total cholesterol( TC)were observed and compared between two groups. Moreover,the carotid intima-media thickness( IMT),left ventricular enddiastolic diameter( LVDD) and left ventricular ejection fraction( LVEF) before and after treatment were detected and compared between two groups. Results The SBP and DBP were decreased significantly in both groups after treatment,moreover,which in observation group were significantly lower than those in control group( P〈0. 01). There were no significant differences in the levels of HDL-C before and after treatment between two groups( P〈0. 05),however,the levels of LDL-C,TG and TC were significantly decreased after treatment,moreover,which in observation group were significantly lower than those in control group( P〈0. 01). After treatment,the IMT thickness and LVDD were significantly decreased in both groups,however,the LVEF levels were significantly increased,there were significant differences between two groups( P〈0. 01). Conclusion On the basis of conventional antihypertension therapy,the atorvastatin calcium can significantly decrease blood pressure, improve blood lipid levels, improve cardiac function and reduce IMT thickness to delay atherosclerosis in patients with hypertension complicated by coronary heart disease.
作者 石辉进 SHI Huijin.(Women and Children' s Hospital of Meizhou City, Guangdong , Meizhou 514021, Chin)
出处 《河北医药》 CAS 2018年第11期1733-1735,共3页 Hebei Medical Journal
关键词 阿托伐他汀钙 高血压 冠心病 IMT厚度 血脂 心功能 atorvastatin calcium hypertension coronary-heart disease IMT thickness blood lipid cardiac function
  • 相关文献

参考文献12

二级参考文献100

  • 1李莉,徐迎红,徐燕,苏克文,周茂松.老年高血压患者颈动脉粥样硬化与心血管危险因素分析[J].实用心脑肺血管病杂志,2010,18(12):1763-1765. 被引量:26
  • 2闫炳乾,田常锁,张志莲.洛伐他汀治疗老年人高脂血症48例[J].中国临床保健杂志,2007,10(4):408-409. 被引量:9
  • 3中华人民共和国卫生部.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002.68-74.
  • 4陈灏珠,主编.心脏病学[M].北京:人民卫生出版社,2003.1001.
  • 5中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版).高血压杂志,2005,134:2-2.
  • 6中华人民共和国卫生部心血管病研究中心.中国高血压防治指南(2009年修汀版)[S].北京:人民卫生出版社,2009:85-8.
  • 7Iglesias del Sol A, Bots ML, Grobbee DE, et al. Carotid intima - media thickness at different sites: relation to incident myocardial infar- action; The Rotterdam Study [ J]. Eur Heart J, 2002, 23 (12): 934 - 940.
  • 8Parissis JT, Korovesis S, Giazitsoglou E, et al. Plasma profiles of Peripheral monocyte - related inflamnmtoty markers in patients with ar- terial hyle, rtension. Correlations with plasma endothelin -1 [J]. In- ternational J Cardiol, 2002, 83 (1) : 13 -21.
  • 9Derhaschnig U, Shehata M, Herkner H, et al. Increased levels of transforming growth factor betal in essential hypertension [ J]. Am J Hypertension, 2002, 15 (3): 207-211.
  • 10Hansen PR, Rieneck K, Bendtzen K, et al. Spironolactone inhibits production of prointlammatory cytokines by human mononuclear cells [J]. Inununol Lett, 2007, 91 (1): 67-68.

共引文献441

同被引文献200

引证文献26

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部